Literature DB >> 25062556

Iloprost prevents doxorubicin mediated human cardiac progenitor cell depletion.

Junping Sun1, Jia Zhang2, Wen Yan1, Cai Chen1, Geru Wu1, Shahrzad Abbasi1, Bao Pham1, Steven Lee1, Jie Cheng3, Nada B Memon4, Yutao Xi5.   

Abstract

Entities:  

Keywords:  Cardiac progenitor cells; Cardiotoxicity; Doxorubicin; Iloprost

Mesh：

Substances：

Year:  2014        PMID： 25062556     DOI： 10.1016/j.ijcard.2014.07.031

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  2 in total

Review 1.  Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity.

Authors:  Jing Zhang; Xiaohai Cui; Yan Yan; Min Li; Ya Yang; Jiansheng Wang; Jia Zhang
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

2.  Engineered M13 Peptide Carrier Promotes Angiogenic Potential of Patient-Derived Human Cardiac Progenitor Cells and In Vivo Engraftment.

Authors:  Woong Bi Jang; Seung Taek Ji; Ji Hye Park; Yeon-Ju Kim; Songhwa Kang; Da Yeon Kim; Na-Kyung Lee; Jin Su Kim; Hye Ji Lim; Jaewoo Choi; Thi Hong Van Le; Thanh Truong Giang Ly; Vinoth Kumar Rethineswaran; Dong Hwan Kim; Jong Seong Ha; Jisoo Yun; Sang Hong Baek; Sang-Mo Kwon
Journal:  Tissue Eng Regen Med       Date:  2020-03-29       Impact factor: 4.169
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.